Health impact, budget impact, and price threshold for cost-effectiveness of lenacapavir for HIV pre-exposure prophylaxis in eastern and southern Africa: a modelling analysis

Authors

Institutions

Publication Details

Journal
The Lancet HIV
Published
2024-09-20
DOI
https://doi.org/10.1016/s2352-3018(24)00239-x
Citations
24
Primary Topic
HIV/AIDS Research and Interventions
Type
article
Field-Weighted Citation Impact
9.34

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Health impact, budget impact, and price threshold for cost-effectiveness of lenacapavir for HIV pre-exposure prophylaxis in eastern and southern Africa: a modelling analysis

Monisha Sharma, Brian Pfau, Nishali Patel, Edinah Mudimu et al.
24 citations
The Lancet HIV
HIV/AIDS Research and Interventions
9.34
article

Health impact, budget impact, and price threshold for cost-effectiveness of lenacapavir for HIV pre-exposure prophylaxis in eastern and southern Africa: a modelling analysis

Monisha Sharma, Brian Pfau, Nishali Patel, Edinah Mudimu, Linxuan Wu, David Kaftan, Anna Bershteyn, Rachel Wittenauer, Cory Arrouzet, Arden L. Saravis
article en
24 citations

Abstract

No abstract available for this paper.
The Lancet HIVVol. 11(11)
University of South Africa (ZA), University of Washington (US), New York University (US)
Bill and Melinda Gates Foundation
Good health and well-being
Openalex Percentile: Top 1%
HIV/AIDS Research and Interventions
9.34
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.